ZURICH: Roche Holding has extended until May 2 its US$4.3 billion offer for U.S. gene therapy specialist Spark Therapeutics, the Swiss drugmaker said after getting only 29.4 percent of Spark's shares in a tender originally due to end on Wednesday.Advertisement
"All terms and conditions of the offer shall remain unchanged during the extended period," Roche said in a statement on the US$114.50 per share offer it announced in February.Roche offered more than twice the Philadelphia-based company's closing price on Feb. 22 for a portfolio that includes a blindness treatment that has U.S. and European approval and other projects for haemophilia and neurodegenerative disorders like Huntington's disease.
The offer comes as rivals, including Novartis, also move aggressively into gene therapy, where treatments for rare, inherited diseases command some of the highest prices in medicine. Spark's blindness therapy Luxturna is priced at US$850,000 per patient.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: thenewpaper - 🏆 7. / 63 Read more »
Yesterday's Kranji barrier trial resultsTRIAL 1 (ORT/PRACTICE) 1 Elcarim Win (G Boss) ORT * 2 Ma Bao Bao (S John) 3 Pure Spark (I Saifudin) * 4 Eastern Victory (N * anafi) Margins and time: 13/4, 1/2, nk (1min 01.97sec) TRIAL 2 (TEST) 1 Lim's...
Source: thenewpaper - 🏆 7. / 63 Read more »
Source: BusinessTimes - 🏆 15. / 51 Read more »
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: TODAYonline - 🏆 1. / 99 Read more »
Lyft shares surge 21.2 percent on Nasdaq debut after IPOLyft Inc shares on Friday opened up 21.2 percent at US$87.24 in its market debut on the Nasdaq after the company was valued at US$24.3 billion in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »